NCT04788966

Brief Summary

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

1.1 years

First QC Date

February 19, 2021

Last Update Submit

March 4, 2021

Conditions

Diagnoses Disease

Keywords

Translation toolAnamnesis

Outcome Measures

Primary Outcomes (3)

  • Satisfaction evaluation through a 4-point scale survey

    Are patients' and doctors' satisfied with the use of BabelDr?

    During the consultation

  • Efficacy evaluation through a 2-point scale survey

    Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?

    During the consultation

  • Technical features evaluation through a 4-point scale survey

    Are the technical features appreciated by the doctors'?

    During the consultation

Interventions

the translation tool BabelDrDEVICE

Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

30 patients were recruited with an average age of M=38.2 (SD=16.49) of which 53.33% were males. The distribution between the different languages was the following: Spanish (11), Arabic (4), Farsi (7), Tigrinya (7) and Albanian (1).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Geneva (HUG)

Geneva, 1205, Switzerland

Location

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 9, 2021

Study Start

November 29, 2018

Primary Completion

January 20, 2020

Study Completion

January 20, 2020

Last Updated

March 9, 2021

Record last verified: 2021-03

Locations

CH(1)